Jue Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jue Wang has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
- Guanghui Huang
Faculty of Humanities and Arts, Macau University of Science and Technology, Macau, China
13 shared publications - Qibiao Wu
Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, China
12 shared publications - Xuexing Luo
College of Arts and Design, Lingnan Normal University
7 shared publications Xuexing Luo
Faculty of Humanities and Arts, Macau University of Science and Technology, Macao, Macao SAR, China
5 shared publicationsAijia Zhang
Faculty of Humanities and Arts, Macau University of Science and Technology, Avenida Wai Long, Taipa, 999078, Macau, China
4 shared publications- Jing Xu
Macau University of Science and Technology
4 shared publications
Latest Publications
- Open Access
- 18 November 2026
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 14, e91108
New Insights and Effectiveness of Digital Interventions for Health Anxiety: Systematic Review and Meta-Analysis
Background: Health anxiety (HA), classified in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5 ) under illness anxiety disorder (IAD) or somatic symptom disorder, is an increasingly prevalent condition associated with substantial psychological and health care burdens. Digital mental health interventions (DMHIs) offer scalable and accessible approaches to care, with digital behavioral interventions (DBIs), particularly internet-delivered cognitive and behavioral therapies, among the most frequently studied. However, their effectiveness in reducing HA has not been comprehensively synthesized. Objective: This study aimed to systematically evaluate the effectiveness of DBIs for reducing HA in adults and to examine their effects on related psychological outcomes. Methods: This systematic review and meta-analysis followed the PRISMA 2020 statement and Cochrane guidance. PubMed, Embase, Web of Science, ScienceDirect, PsycINFO, and the Cochrane Library were searched from database inception to November 1, 2025. Eligible studies included randomized controlled trials (RCTs), quasi-experimental studies, and cohort studies involving adults with HA. HA severity was the primary outcome. Random-effects meta-analyses were restricted to RCTs. Methodological quality was appraised using Joanna Briggs Institute tools, risk of bias in RCTs using Risk of Bias 2 (RoB 2), and certainty of evidence using Grading of Recommendations Assessment, Development, and Evaluation (GRADE). Results: Sixteen studies involving 2581 participants were included, comprising 9 RCTs, 6 quasi-experimental studies, and 1 cohort study. Six RCTs involving 585 participants contributed to the primary meta-analysis. Digital interventions significantly reduced HA compared with control conditions (Hedges g =−0.77, 95% CI −1.25 to –0.30; P =.002), although between-study heterogeneity was substantial ( I ²=86.7%). Leave-one-out analyses showed that this effect remained significant after exclusion of any individual trial. By contrast, pooled effects on illness-related attitudes, general anxiety, anxiety sensitivity, and depressive symptoms were not statistically significant and were characterized by substantial heterogeneity. Among the 9 RCTs, 4 were judged as having low overall risk of bias, 2 had some concerns, and 3 were at high risk. GRADE certainty was low for HA and very low for the secondary outcomes. Conclusions: Digital interventions show potential for reducing core health-anxiety symptoms, but confidence in the magnitude and generalizability of the effect is limited by substantial heterogeneity, risk-of-bias concerns, and low certainty of evidence. Evidence for broader psychological outcomes remains inconclusive. Adequately powered, well-reported RCTs using rigorous outcome assessment, appropriate active comparators, and longer follow-up are needed to confirm effectiveness and clarify which patients benefit most and under what delivery conditions.
- 18 November 2026
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 14, e91108
Open AccessNew Insights and Effectiveness of Digital Interventions for Health Anxiety: Systematic Review and Meta-Analysis
Background: Health anxiety (HA), classified in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5 ) under illness anxiety disorder (IAD) or somatic symptom disorder, is an increasingly prevalent condition associated with substantial psychological and health care burdens. Digital mental health interventions (DMHIs) offer scalable and accessible approaches to care, with digital behavioral interventions (DBIs), particularly internet-delivered cognitive and behavioral therapies, among the most frequently studied. However, their effectiveness in reducing HA has not been comprehensively synthesized. Objective: This study aimed to systematically evaluate the effectiveness of DBIs for reducing HA in adults and to examine their effects on related psychological outcomes. Methods: This systematic review and meta-analysis followed the PRISMA 2020 statement and Cochrane guidance. PubMed, Embase, Web of Science, ScienceDirect, PsycINFO, and the Cochrane Library were searched from database inception to November 1, 2025. Eligible studies included randomized controlled trials (RCTs), quasi-experimental studies, and cohort studies involving adults with HA. HA severity was the primary outcome. Random-effects meta-analyses were restricted to RCTs. Methodological quality was appraised using Joanna Briggs Institute tools, risk of bias in RCTs using Risk of Bias 2 (RoB 2), and certainty of evidence using Grading of Recommendations Assessment, Development, and Evaluation (GRADE). Results: Sixteen studies involving 2581 participants were included, comprising 9 RCTs, 6 quasi-experimental studies, and 1 cohort study. Six RCTs involving 585 participants contributed to the primary meta-analysis. Digital interventions significantly reduced HA compared with control conditions (Hedges g =−0.77, 95% CI −1.25 to –0.30; P =.002), although between-study heterogeneity was substantial ( I ²=86.7%). Leave-one-out analyses showed that this effect remained significant after exclusion of any individual trial. By contrast, pooled effects on illness-related attitudes, general anxiety, anxiety sensitivity, and depressive symptoms were not statistically significant and were characterized by substantial heterogeneity. Among the 9 RCTs, 4 were judged as having low overall risk of bias, 2 had some concerns, and 3 were at high risk. GRADE certainty was low for HA and very low for the secondary outcomes. Conclusions: Digital interventions show potential for reducing core health-anxiety symptoms, but confidence in the magnitude and generalizability of the effect is limited by substantial heterogeneity, risk-of-bias concerns, and low certainty of evidence. Evidence for broader psychological outcomes remains inconclusive. Adequately powered, well-reported RCTs using rigorous outcome assessment, appropriate active comparators, and longer follow-up are needed to confirm effectiveness and clarify which patients benefit most and under what delivery conditions.
- Open Access
- 5 September 2026
- Published by Springer Nature in BMC Gastroenterology
Increasing mortality burden among U.S. cancer patients with liver cirrhosis, 1999–2023
- 5 September 2026
- Published by Springer Nature in BMC Gastroenterology
Open AccessIncreasing mortality burden among U.S. cancer patients with liver cirrhosis, 1999–2023
- Open Access
- 1 July 2026
- Published by Taylor & Francis in Breast Cancer: Targets and Therapy
- Vol. ume 18, 1-16
AIM2 Lactylation Regulates Radiotherapy Sensitivity in Triple-Negative Breast Cancer
Background: Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with limited targeted treatment options. Radiotherapy remains an important therapeutic approach for TNBC, but radioresistance markedly limits its efficacy. Absent in melanoma 2 (AIM2) has been increasingly implicated in tumor biology and innate immune signaling; however, its role in TNBC radioresistance and its regulation by the lactate-rich tumor microenvironment remain unclear. Methods: Radiation-resistant TNBC cell models were established from BT-549 and MDA-MB-231 cells by repeated fractional irradiation. AIM2 knockdown and IRF3 overexpression were achieved by lentiviral transduction. Cell proliferation, colony formation, apoptosis, protein expression, AIM2 lactylation, subcellular localization, and AIM2–IRF3 interaction were evaluated using CCK-8 assay, colony formation assay, flow cytometry, RT-qPCR, Western blotting, co-immunoprecipitation, and immunofluorescence. Bioinformatics analyses were performed to assess the potential prognostic relevance of AIM2. In vitro experiments were performed with at least three independent biological replicates. Results: Radiation treatment increased AIM2 expression in TNBC cells. AIM2 knockdown reduced colony formation and promoted apoptosis in radioresistant TNBC cells. High-lactate conditions decreased AIM2 expression, increased AIM2 lactylation, and promoted AIM2 nuclear translocation. IRF3 overexpression partially reversed the effects of AIM2 knockdown on colony formation and apoptosis, whereas lactate treatment weakened the interaction between AIM2 and IRF3. Bioinformatics analyses indicated that elevated AIM2 expression was associated with poorer prognosis. Conclusion: These findings suggest that AIM2 may be involved in the regulation of TNBC radioresistance, potentially through its interaction with IRF3. High-lactate conditions may affect this regulatory axis by enhancing AIM2 lactylation. This study provides preliminary evidence for a potential mechanism linking lactate-mediated post-translational modification with radiosensitivity regulation in TNBC; however, further mechanistic, in vivo, and clinical validation is required.
- 1 July 2026
- Published by Taylor & Francis in Breast Cancer: Targets and Therapy
- Vol. ume 18, 1-16
Open AccessAIM2 Lactylation Regulates Radiotherapy Sensitivity in Triple-Negative Breast Cancer
Background: Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with limited targeted treatment options. Radiotherapy remains an important therapeutic approach for TNBC, but radioresistance markedly limits its efficacy. Absent in melanoma 2 (AIM2) has been increasingly implicated in tumor biology and innate immune signaling; however, its role in TNBC radioresistance and its regulation by the lactate-rich tumor microenvironment remain unclear. Methods: Radiation-resistant TNBC cell models were established from BT-549 and MDA-MB-231 cells by repeated fractional irradiation. AIM2 knockdown and IRF3 overexpression were achieved by lentiviral transduction. Cell proliferation, colony formation, apoptosis, protein expression, AIM2 lactylation, subcellular localization, and AIM2–IRF3 interaction were evaluated using CCK-8 assay, colony formation assay, flow cytometry, RT-qPCR, Western blotting, co-immunoprecipitation, and immunofluorescence. Bioinformatics analyses were performed to assess the potential prognostic relevance of AIM2. In vitro experiments were performed with at least three independent biological replicates. Results: Radiation treatment increased AIM2 expression in TNBC cells. AIM2 knockdown reduced colony formation and promoted apoptosis in radioresistant TNBC cells. High-lactate conditions decreased AIM2 expression, increased AIM2 lactylation, and promoted AIM2 nuclear translocation. IRF3 overexpression partially reversed the effects of AIM2 knockdown on colony formation and apoptosis, whereas lactate treatment weakened the interaction between AIM2 and IRF3. Bioinformatics analyses indicated that elevated AIM2 expression was associated with poorer prognosis. Conclusion: These findings suggest that AIM2 may be involved in the regulation of TNBC radioresistance, potentially through its interaction with IRF3. High-lactate conditions may affect this regulatory axis by enhancing AIM2 lactylation. This study provides preliminary evidence for a potential mechanism linking lactate-mediated post-translational modification with radiosensitivity regulation in TNBC; however, further mechanistic, in vivo, and clinical validation is required.
- Open Access
- 18 June 2026
- Published by Wiley in Carbon Neutralization
- Vol. 5 (4)
Hybrid Cell Membrane‐Coated NIR‐Photodegradable Carbon Nitride Nanozymes for Mangiferin Dual‐Targeted Delivery and Gas Mild Photothermal Immunotherapy Against Liver Fibrosis via the HIF‐1α/HSP27 Axis
Hypoxia, a hallmark pathological feature of liver fibrosis, upregulates HIF‐1α expression to drive hepatic stellate cell (HSC) activation, resulting in fibrotic lesions. Targeting activated HSCs (aHSCs) and achieving efficient liver fibrosis treatment remain daunting challenges. For the first time, we constructed a biomimetic carbon nitride‐based drug–gas codelivery platform HMCCNs@MAN for precise mild photothermal immunotherapy (< 45°C) for liver fibrosis. Specifically, by utilizing the immunocamouflage and fibrosis‐targeting properties of macrophage (MΦ) membranes, along with the homologous targeting ability of aHSCs membranes, the hybrid MΦ‐aHSC membrane‐coated, carbon dot‐doped carbon nitride (HMCCNs) achieved a dual‐targeted delivery of mangiferin (MAN) to liver fibrosis lesions. At the lesion site, HMCCNs enabled NIR‐triggered water splitting to produce oxygen and exhibited catalase‐like enzymatic activity, synergistically ameliorating hypoxic conditions. Simultaneously, HMCCNs demonstrated a high photothermal conversion efficiency of 69.52%. Furthermore, the photocorrosive effect endowed HMCCNs@MAN with significant NIR‐responsive drug release capability. Released MAN and generated oxygen cooperatively modulated the HIF‐1α/HSP27 axis, leading to an increased sensitivity of fibrotic lesions to thermotherapy. Notably, HMCCNs@MAN + NIR activated natural killer cells, thereby enhancing the immune response against aHSCs. This study reveals the great potential of HMCCNs@MAN as a mild photothermal‐immunotherapy strategy for liver fibrosis treatment.
- 18 June 2026
- Published by Wiley in Carbon Neutralization
- Vol. 5 (4)
Open AccessHybrid Cell Membrane‐Coated NIR‐Photodegradable Carbon Nitride Nanozymes for Mangiferin Dual‐Targeted Delivery and Gas Mild Photothermal Immunotherapy Against Liver Fibrosis via the HIF‐1α/HSP27 Axis
Hypoxia, a hallmark pathological feature of liver fibrosis, upregulates HIF‐1α expression to drive hepatic stellate cell (HSC) activation, resulting in fibrotic lesions. Targeting activated HSCs (aHSCs) and achieving efficient liver fibrosis treatment remain daunting challenges. For the first time, we constructed a biomimetic carbon nitride‐based drug–gas codelivery platform HMCCNs@MAN for precise mild photothermal immunotherapy (< 45°C) for liver fibrosis. Specifically, by utilizing the immunocamouflage and fibrosis‐targeting properties of macrophage (MΦ) membranes, along with the homologous targeting ability of aHSCs membranes, the hybrid MΦ‐aHSC membrane‐coated, carbon dot‐doped carbon nitride (HMCCNs) achieved a dual‐targeted delivery of mangiferin (MAN) to liver fibrosis lesions. At the lesion site, HMCCNs enabled NIR‐triggered water splitting to produce oxygen and exhibited catalase‐like enzymatic activity, synergistically ameliorating hypoxic conditions. Simultaneously, HMCCNs demonstrated a high photothermal conversion efficiency of 69.52%. Furthermore, the photocorrosive effect endowed HMCCNs@MAN with significant NIR‐responsive drug release capability. Released MAN and generated oxygen cooperatively modulated the HIF‐1α/HSP27 axis, leading to an increased sensitivity of fibrotic lesions to thermotherapy. Notably, HMCCNs@MAN + NIR activated natural killer cells, thereby enhancing the immune response against aHSCs. This study reveals the great potential of HMCCNs@MAN as a mild photothermal‐immunotherapy strategy for liver fibrosis treatment.
- Open Access
- 16 January 2026
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 18 (1)
The application of AI-based interventions in diabetes personalized management: a systematic review and meta-analysis
Artificial intelligence (AI)–based interventions are increasingly integrated into diabetes management, but the certainty of their clinical benefits r
- 16 January 2026
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 18 (1)
Open AccessThe application of AI-based interventions in diabetes personalized management: a systematic review and meta-analysis
Artificial intelligence (AI)–based interventions are increasingly integrated into diabetes management, but the certainty of their clinical benefits r
- Open Access
- 9 January 2026
- Published by JMIR Publications Inc. in JMIR Preprints
New insights and effectiveness of digital interventions for Health Anxiety: a systematic review and meta-analysis (Preprint)
BACKGROUND Health anxiety, commonly diagnosed in the DSM-5 as illness anxiety disorder (IAD) or somatic symptom disorder, is an increasingly prevalent condition that imposes a substantial burden on healthcare systems. Digital mental health interventions (DMHIs), owing to their scalability and cost-effectiveness, have been proposed as promising approaches for managing health anxiety. However, the overall effectiveness of digital behavioral interventions for alleviating health anxiety has not yet been comprehensively evaluated through systematic review and meta-analysis. OBJECTIVE To systematically evaluate the clinical effectiveness of digital behavioral interventions for reducing health anxiety in adults and to examine effects on related psychological outcomes. METHODS This systematic review and meta-analysis adhered to the PRISMA 2020 statement and Cochrane guidelines. We systematically searched PubMed, Embase, Web of Science, and ScienceDirect from database inception to 1 November 2025. Eligible studies included randomized controlled trials (RCTs), quasi-experimental studies, and cohort studies involving adults with health anxiety. The primary outcome was health anxiety severity assessed using validated instruments. Meta-analyses employed random-effects models to estimate standardized mean differences (SMDs) with 95% confidence intervals (CIs). Study quality was appraised using JBI guidelines, and risk of bias for RCTs was assessed with the Cochrane ROB 2 tool. RESULTS This systematic review included 16 studies (2014–2025; N=2,481), primarily evaluating internet-delivered behavioral therapies, particularly iCBT. RoB 2 assessments of nine RCTs indicated generally low risk for randomization and deviations from intended interventions, with some concerns regarding missing outcome data, outcome measurement, and selective reporting. Meta-analysis showed significant reductions in core health anxiety symptoms: HAI (3 studies) SMD=−0.96 (95% CI −1.78 to −0.12) and SHAI (4 studies) SMD=−0.81 (95% CI −1.45 to −0.16). Digital interventions also showed potential benefits for comorbid general anxiety (BAI) and depressive symptoms (MADRS-S). Heterogeneity was high across outcomes (I²>80%), likely reflecting differences in samples, protocols, and measures; sensitivity analyses supported the robustness of effects on core health anxiety. CONCLUSIONS Digitally assisted cognitive and behavioral therapies represent a well-established and effective approach for alleviating health anxiety, with intervention effects delivered via smart devices comparable to the quality of face-to-face behavioral treatments. Internet-based platforms offer a feasible means of enhancing patient engagement and have demonstrated significant short-term efficacy in reducing core health anxiety symptoms, along with potential for sustained improvement. Future research should prioritize direct comparisons between internet-based and face-to-face CBT and explore the integration of embodied interaction modalities, such as visualization and voice-based interaction, to optimize therapeutic outcomes CLINICALTRIAL Prospero Registration Number: CRD420251238746
- 9 January 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessNew insights and effectiveness of digital interventions for Health Anxiety: a systematic review and meta-analysis (Preprint)
BACKGROUND Health anxiety, commonly diagnosed in the DSM-5 as illness anxiety disorder (IAD) or somatic symptom disorder, is an increasingly prevalent condition that imposes a substantial burden on healthcare systems. Digital mental health interventions (DMHIs), owing to their scalability and cost-effectiveness, have been proposed as promising approaches for managing health anxiety. However, the overall effectiveness of digital behavioral interventions for alleviating health anxiety has not yet been comprehensively evaluated through systematic review and meta-analysis. OBJECTIVE To systematically evaluate the clinical effectiveness of digital behavioral interventions for reducing health anxiety in adults and to examine effects on related psychological outcomes. METHODS This systematic review and meta-analysis adhered to the PRISMA 2020 statement and Cochrane guidelines. We systematically searched PubMed, Embase, Web of Science, and ScienceDirect from database inception to 1 November 2025. Eligible studies included randomized controlled trials (RCTs), quasi-experimental studies, and cohort studies involving adults with health anxiety. The primary outcome was health anxiety severity assessed using validated instruments. Meta-analyses employed random-effects models to estimate standardized mean differences (SMDs) with 95% confidence intervals (CIs). Study quality was appraised using JBI guidelines, and risk of bias for RCTs was assessed with the Cochrane ROB 2 tool. RESULTS This systematic review included 16 studies (2014–2025; N=2,481), primarily evaluating internet-delivered behavioral therapies, particularly iCBT. RoB 2 assessments of nine RCTs indicated generally low risk for randomization and deviations from intended interventions, with some concerns regarding missing outcome data, outcome measurement, and selective reporting. Meta-analysis showed significant reductions in core health anxiety symptoms: HAI (3 studies) SMD=−0.96 (95% CI −1.78 to −0.12) and SHAI (4 studies) SMD=−0.81 (95% CI −1.45 to −0.16). Digital interventions also showed potential benefits for comorbid general anxiety (BAI) and depressive symptoms (MADRS-S). Heterogeneity was high across outcomes (I²>80%), likely reflecting differences in samples, protocols, and measures; sensitivity analyses supported the robustness of effects on core health anxiety. CONCLUSIONS Digitally assisted cognitive and behavioral therapies represent a well-established and effective approach for alleviating health anxiety, with intervention effects delivered via smart devices comparable to the quality of face-to-face behavioral treatments. Internet-based platforms offer a feasible means of enhancing patient engagement and have demonstrated significant short-term efficacy in reducing core health anxiety symptoms, along with potential for sustained improvement. Future research should prioritize direct comparisons between internet-based and face-to-face CBT and explore the integration of embodied interaction modalities, such as visualization and voice-based interaction, to optimize therapeutic outcomes CLINICALTRIAL Prospero Registration Number: CRD420251238746
- Open Access
- 17 December 2025
- Published by Springer Nature in Critical Care
- Vol. 30 (1)
Mitochondrial regulation of lactylation in sepsis-induced cardiomyopathy
Sepsis-induced cardiomyopathy (SICM) is a life-threatening complication of sepsis that is characterized by acute cardiac dysfunction and is associated with
- 17 December 2025
- Published by Springer Nature in Critical Care
- Vol. 30 (1)
Open AccessMitochondrial regulation of lactylation in sepsis-induced cardiomyopathy
Sepsis-induced cardiomyopathy (SICM) is a life-threatening complication of sepsis that is characterized by acute cardiac dysfunction and is associated with
- Open Access
- 31 October 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (44) , e45020
The impact of mind-body therapies on the mental health of caregivers in palliative care settings: A systematic review
Background: Caregivers in palliative care settings often face significant emotional and psychological burdens, yet their mental health needs remain under-addressed. Mind-body therapies (MBTs) have shown promise in clinical populations, but their effects on caregivers are understudied and poorly synthesized. Methods: This systematic review followed PRISMA 2020 guidelines and was registered with PROSPERO (CRD42024571202). A comprehensive search of PubMed, EMBASE, Web of Science, and Cochrane Library identified randomized controlled trials (RCTs) and quasi-experimental studies (QES) assessing MBTs for caregivers in palliative care. Data were extracted using the PICOS framework. Study quality was appraised using JBI tools, risk of bias was assessed via ROB2 and ROBINS-I, and evidence certainty was rated with GRADE. Results: 20 studies involving 1230 caregivers were included. Interventions encompassed 8 types of MBTs, with structured, therapist-guided formats demonstrating stronger effects than self-directed or digital approaches. Overall, MBTs showed short-term improvements in depression, anxiety, PTSD, distress, quality of life, and self-regulation. Informal and home hospice caregivers benefited most, while professional and spousal caregivers showed variable responsiveness. Methodological heterogeneity and limited follow-up constrained meta-analysis and generalizability. Conclusion: This review presents a comprehensive synthesis of existing evidence on MBTs targeting caregiver mental health in palliative care. It highlights the therapeutic potential of MBTs and identifies delivery modality and caregiver role as key moderators of intervention effectiveness. Furthermore, it contributes to the field by outlining practical implementation strategies for integrating MBTs into routine caregiver support, with an emphasis on contextual adaptation and policy-level facilitation. These findings support the development of scalable, person-centered interventions to meet the psychological needs of caregivers within palliative care systems.
- 31 October 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (44) , e45020
Open AccessThe impact of mind-body therapies on the mental health of caregivers in palliative care settings: A systematic review
Background: Caregivers in palliative care settings often face significant emotional and psychological burdens, yet their mental health needs remain under-addressed. Mind-body therapies (MBTs) have shown promise in clinical populations, but their effects on caregivers are understudied and poorly synthesized. Methods: This systematic review followed PRISMA 2020 guidelines and was registered with PROSPERO (CRD42024571202). A comprehensive search of PubMed, EMBASE, Web of Science, and Cochrane Library identified randomized controlled trials (RCTs) and quasi-experimental studies (QES) assessing MBTs for caregivers in palliative care. Data were extracted using the PICOS framework. Study quality was appraised using JBI tools, risk of bias was assessed via ROB2 and ROBINS-I, and evidence certainty was rated with GRADE. Results: 20 studies involving 1230 caregivers were included. Interventions encompassed 8 types of MBTs, with structured, therapist-guided formats demonstrating stronger effects than self-directed or digital approaches. Overall, MBTs showed short-term improvements in depression, anxiety, PTSD, distress, quality of life, and self-regulation. Informal and home hospice caregivers benefited most, while professional and spousal caregivers showed variable responsiveness. Methodological heterogeneity and limited follow-up constrained meta-analysis and generalizability. Conclusion: This review presents a comprehensive synthesis of existing evidence on MBTs targeting caregiver mental health in palliative care. It highlights the therapeutic potential of MBTs and identifies delivery modality and caregiver role as key moderators of intervention effectiveness. Furthermore, it contributes to the field by outlining practical implementation strategies for integrating MBTs into routine caregiver support, with an emphasis on contextual adaptation and policy-level facilitation. These findings support the development of scalable, person-centered interventions to meet the psychological needs of caregivers within palliative care systems.
- 30 October 2025
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 95, 103277
Corrigendum to “AI-assisted drawing therapy for children with ADHD: A randomised controlled trial” [Complement Ther Med 94 (2025) 103262]
- 30 October 2025
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 95, 103277
Corrigendum to “AI-assisted drawing therapy for children with ADHD: A randomised controlled trial” [Complement Ther Med 94 (2025) 103262]
- Open Access
- 15 October 2025
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 94, 103262
AI-assisted drawing therapy for children with ADHD: A randomised controlled trial
- 15 October 2025
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 94, 103262
Open AccessAI-assisted drawing therapy for children with ADHD: A randomised controlled trial